Evidence map›Paper›PMID 42223882›Full record

ArticleNeurology and therapy2026

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

Bruno Brochet, Dawn Langdon, Eva Kubala Havrdova, Jeanette Lechner-Scott, Xavier Montalban, Francesco Patti, Fredrik Piehl, Alessandra Solari, Raymond Hupperts, Nektaria Alexandri and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bruno BrochetINSERM U1215, University of Bordeaux, Bordeaux, France. bruno.brochet@u-bordeaux.fr.ORCID http://orcid.org/0000-0003-3824-2796
Dawn LangdonDepartment of Psychology, Royal Holloway, University of London, Egham, Surrey, UK.ORCID http://orcid.org/0000-0003-1128-7417
Eva Kubala HavrdovaFirst Medical Faculty, Department of Neurology and Center for Clinical Neuroscience, Charles University, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-9543-4359
Jeanette Lechner-ScottUniversity of Newcastle, Newcastle, NSW, Australia.ORCID http://orcid.org/0000-0002-3850-447X
Xavier MontalbanDepartment of Neurology-Neuroimmunology Centre of Multiple Sclerosis of Catalonia (Cemcat), University Hospital Vall d'Hebron, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0098-9918
Francesco PattiDepartment of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, and Azienda Ospedaliero Universitaria Policlinico "G Rodolico"- San Marco, University of Catania, Catania, Italy.ORCID http://orcid.org/0000-0002-6923-0846
Fredrik PiehlDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8329-5219
Alessandra SolariUnit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.ORCID http://orcid.org/0000-0001-9930-7579
Raymond HuppertsZuyderland Medisch Centrum Sittard, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0003-2106-2158
Nektaria AlexandriMerck Healthcare KGaA, Darmstadt, Germany.ORCID http://orcid.org/0000-0002-9806-8358
Annette LehnMerck Healthcare KGaA, Darmstadt, Germany.ORCID http://orcid.org/0000-0002-1083-9796
Andrzej SmykMerck Healthcare KGaA, Darmstadt, Germany.ORCID http://orcid.org/0000-0002-7794-112X
Krzysztof SelmajCenter for Neurology, Lodz, Poland.ORCID http://orcid.org/0000-0003-1213-7218
CLARIFY-MS Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42223882
PMCPMC13396051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.